In a patient with Trisomy 21 (Down syndrome) who has incidental intracranial calcifications, what are the typical locations and appearance, and what evaluation and management are recommended?

Intracranial Calcifications in Trisomy 21 (Down Syndrome)

Basal ganglia calcifications are the characteristic intracranial finding in patients with Down syndrome, though they are relatively uncommon and typically incidental without specific clinical significance. 1

Typical Locations and Appearance

In Down syndrome, when intracranial calcifications occur, they most commonly affect:

• Basal ganglia - the primary location reported in the literature 1
• Calcifications appear as nodular densities on CT imaging
• These are typically bilateral in distribution

Important distinction: The calcification pattern in Down syndrome differs markedly from other conditions. Unlike tuberous sclerosis (which shows periventricular nodular calcifications) or TORCH infections (which show scattered parenchymal or periventricular calcifications), Down syndrome specifically involves the basal ganglia 1, 2.

Clinical Significance

These calcifications are generally:

• Incidental findings discovered on neuroimaging performed for other reasons
• Not associated with specific neurological symptoms related to the calcifications themselves
• Not visualized on plain radiographs if CT attenuation values are less than 200 Hounsfield units 1

Recommended Evaluation

When intracranial calcifications are discovered in a patient with Down syndrome:

1. Exclude Secondary Metabolic Causes

Even though basal ganglia calcifications can occur as part of Down syndrome itself, you must rule out treatable conditions:

• Calcium/phosphate metabolism: Measure serum calcium, phosphorus, parathyroid hormone, and magnesium 3

  • Down syndrome patients have increased risk of hypoparathyroidism 4
  • Consider ABCD syndrome (Abnormal calcium/calcinosis/creatinine in Down syndrome) - a rare condition causing hypercalcemia, nephrocalcinosis, and AKI 5

• Thyroid function: TSH, free T4 (annual screening already recommended in Down syndrome) 6, 7

• Renal function: Creatinine, urinalysis - particularly if considering ABCD syndrome 5

2. Neuroimaging Approach

• CT scan is the gold standard for detecting and characterizing intracranial calcifications 1, 2, 8
• MRI is less sensitive for calcifications but useful if evaluating for other pathology
• Document the location, distribution, and extent of calcifications

3. Assess for Associated Conditions

Given the Down syndrome population's specific vulnerabilities 9:

• Cognitive baseline: Document current cognitive function, as all adults with Down syndrome develop Alzheimer's neuropathology by age 40, with 50% showing clinical dementia by age 60 9
• Seizure history: Down syndrome carries 5-7% lifetime epilepsy risk (vs. 0.5-1% in general population), and hypocalcemia can trigger seizures at any age 4
• Cardiovascular history: Congenital heart disease is common and relevant for overall management 10, 6

Management Recommendations

For isolated basal ganglia calcifications with normal metabolic workup:

• No specific treatment required for the calcifications themselves
• Continue routine Down syndrome surveillance per established guidelines 6, 7:
  • Annual thyroid screening
  • Annual vision and hearing assessments
  • Cognitive monitoring, particularly after age 40 for dementia screening 9

If metabolic abnormalities are identified:

• Hypocalcemia/hypoparathyroidism: Daily calcium and vitamin D supplementation; consider active vitamin D metabolites for severe cases 4
• ABCD syndrome: Dietary calcium restriction, close monitoring of renal function and calcium levels 5

If seizures develop:

• Check ionized calcium immediately - hypocalcemic seizures may occur even without prior history 4
• Standard anticonvulsant therapy if seizures persist after calcium normalization
• EEG and repeat neuroimaging indicated for non-hypocalcemic seizures 4

Key Clinical Pitfalls

1. Don't assume all calcifications are benign - always exclude metabolic causes, particularly calcium/parathyroid disorders which are treatable
2. Don't overlook ABCD syndrome - though rare, it's a specific Down syndrome complication requiring different management 5
3. Don't attribute new neurological symptoms to "just the calcifications" - investigate for hypocalcemia, seizures, or early-onset dementia 9, 4
4. Remember the dementia risk - by age 40, neuropathological changes are universal, making cognitive monitoring essential 9